Detalhe da pesquisa
1.
CIGAR-seq, a CRISPR/Cas-based method for unbiased screening of novel mRNA modification regulators.
Mol Syst Biol
; 16(11): e10025, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33251765
2.
Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer.
Lancet
; 399(10328): 905-907, 2022 03 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35090602
3.
ActuAtor, a Listeria-inspired molecular tool for physical manipulation of intracellular organizations through de novo actin polymerization.
Cell Rep
; 42(10): 113089, 2023 10 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37734382
4.
Single cell multi-omics reveal intra-cell-line heterogeneity across human cancer cell lines.
Nat Commun
; 14(1): 8170, 2023 Dec 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38071219
5.
Sotrovimab restores neutralization against current Omicron subvariants in patients with blood cancer.
Cancer Cell
; 41(5): 821-823, 2023 05 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37116490
6.
Functional immune responses against SARS-CoV-2 variants of concern after fourth COVID-19 vaccine dose or infection in patients with blood cancer.
Cell Rep Med
; 3(10): 100781, 2022 10 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36240755
7.
Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study.
Nat Cancer
; 2(12): 1305-1320, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35121899
8.
Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: The CAPTURE study.
Nat Cancer
; 2: 1321-1337, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34950880
9.
Integrative multi-omics analysis of a colon cancer cell line with heterogeneous Wnt activity revealed RUNX2 as an epigenetic regulator of EMT.
Oncogene
; 39(28): 5152-5164, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32535615
10.
Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer.
Cancer Cell
; 40(4): 438, 2022 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35413273
11.
Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer.
Cancer Cell
; 40(2): 114-116, 2022 02 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34968417